Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| MNPR (Monopar Therapeutics Inc.) | -8.91% | 56.44% | 132.22% | 15.85% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 12/20/2019
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| MNPR (Monopar Therapeutics Inc.) | 12/20/2019 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -8.55 | 56.44 | 132.22 | 15.85 | NA | NA | NA | … | … | -8.91 | 212.59 | 1,194.12 | -85.65 | -26.17 | -47.55 | -63.13 | -38.52 |
| Sharpe Ratio | NA | 1.23 | 0.82 | 0.11 | NA | NA | NA | … | … | -0.05 | 2.09 | 4.60 | -0.78 | -0.32 | -0.62 | -0.62 | -0.56 |
| Standard Deviation(%) | NA | 79.52 | 169.05 | 143.08 | NA | NA | NA | … | … | 63.47 | 103.24 | 258.39 | 114.99 | 86.85 | 76.29 | 101.22 | 181.57 |
| Draw Down(%) | NA | 50.89 | 73.15 | 95.53 | NA | NA | NA | … | … | 33.20 | 46.14 | 67.41 | 92.23 | 59.67 | 70.09 | 80.18 | 38.52 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 12/20/2019
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| MNPR (Monopar Therapeutics Inc.) |
-65.73%
Jan 2021 – Jan 2024 |
-9.34%
Jan 2020 – Jan 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| MNPR (Monopar Therapeutics Inc.) |
136.77%
May 2023 – May 2026 |
31.16%
Oct 2020 – Oct 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart